Company news

Entropy Neurodynamics Limited news in 2025

Entropy Neurodynamics Limited's news releases, calls and decks from 2025, newest first.

View company

$847,186 R&D Tax Incentive received

December 18, 2025

First BED patient completes second TRP-8803 infusion

December 15, 2025

First patient successfully dosed in TRP 8803 BED trial

December 1, 2025

BED trial accelerates - enrolment grows, dosing in two weeks

November 17, 2025

$6.1m in new funding to accelerate clinical development

November 4, 2025

Trading Halt

November 2, 2025

First patient enrolled in Binge Eating Disorder Trial

October 13, 2025

Appendix 4E and 2025 Annual Report

August 28, 2025

Landmark EEG Biomarker Agreement for Precision Psychiatry

August 20, 2025

$2.6m in non-dilutive capital funding secured

August 11, 2025

Patient recruitment for world first TRP-8803 trial underway

July 20, 2025

Binge Eating Disorder Trial receives Human Ethics approval

June 22, 2025

TRP-8803 BED trial to commence with Swinburne this quarter

April 9, 2025

Appendix 4D and Half Year Report for period 31 Dec 2024

February 26, 2025

Decks in 2025